INTEGRA Biosciences

INTEGRA Biosciences

Founded in 1965 as a small Swiss engineering firm, INTEGRA Biosciences evolved through the 1980s and 1990s into a specialized manufacturer of laboratory automation tools. The company's growth was fueled by acquisitions of established pipetting brands — including the acquisition of Tecan's pipetting business in 2005 and the Viaflo electronic pipette line — which gave it instant credibility and distribution in the life sciences tools market. Today it operates as a private, founder-led enterprise with manufacturing anchored in Switzerland and a commercial footprint spanning North America, Europe, and Asia. INTEGRA's product portfolio centers on three families: electronic and manual pipettes (the EVOLVE, VOYAGER, and VIAFLO series), benchtop pipetting robots (ASSIST PLUS), and automated media preparation systems (MEDIACLAVE/MEDIAJET). These tools serve cell culture, PCR setup, serial dilution, and plate replication — the exacting, high-repetition steps that consume postdoc and technician time. Confirmed deployments include integration within GLP/GMP workflows at major pharmaceutical and academic labs in the US, Germany, and Japan. The ASSIST PLUS bridges mid-throughput labs that find full liquid-handling stations too costly, a positioning that carves a niche between manual pipetting and large-scale Hamilton or Tecan systems. INTEGRA remains privately held by its founding entities, with estimated revenues in the hundreds of millions (per industry peer analysis, 2023). Its Swiss headquarters oversees R&D and production, while subsidiaries in Hudson, New Hampshire, and Zizers coordinate North American and European sales. In recent years, the firm has leaned into digital calibration and RFID-enabled pipette tracking — features that appeal to regulated labs needing audit trails for compliance. June 2022: Launched the ASSIST PLUS pipetting robot with a modular design that allows labs to adapt the platform across multiple consumable formats (per the firm, June 2022). INTEGRA's structural differentiator is its status as one of the last independent, founder-anchored precision pipette manufacturers operating at global scale. While rivals like Eppendorf and Mettler Toledo bundle pipettes as part of broader portfolios, INTEGRA competes strictly on the ergonomics, reproducibility, and throughput of its liquid-handling products. That single-minded focus — combined with Swiss manufacturing provenance — gives the brand a defensible position in a market where lab protocols are sticky and switching costs are high.